TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34 | -2.9% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $35 | -5.4% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $37 | +8.8% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $34 | -99.9% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $29,000 | -9.4% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $32,000 | 0.0% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $32,000 | +6.7% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $30,000 | -16.7% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | -2.7% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $37,000 | -7.5% | 2,214 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $40,000 | 0.0% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $40,000 | +2.6% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $39,000 | -2.5% | 2,214 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $40,000 | +17.6% | 2,214 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $34,000 | -40.4% | 2,214 | -23.2% | 0.00% | -20.0% |
| Q4 2019 | $57,000 | -3.4% | 2,883 | -14.9% | 0.01% | -16.7% |
| Q3 2019 | $59,000 | -21.3% | 3,386 | -19.9% | 0.01% | -25.0% |
| Q2 2019 | $75,000 | -1.3% | 4,226 | +13.5% | 0.01% | 0.0% |
| Q1 2019 | $76,000 | – | 3,723 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |